Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
186.62
-13.48 (-6.74%)
Oct 26, 2026, 9:42 AM EDT - Market open
Moderna Market Cap
Moderna has a market cap or net worth of $74.51 billion as of October 26, 2026. It is the 307th most valuable company in the world and the 169th biggest in the United States. Its market cap has increased by 613.37% in one year.
Market Cap
74.51B
Enterprise Value
68.88B
1-Year Change
613.37%
Global Rank
Country Rank
#169 United States
Category
ChartMarket Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.12B to $74.51B, an increase of 1,117.72%. That is a compound annual growth rate of 37.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 74.51B | 546.59% |
| Dec 31, 2025 | 11.52B | -27.99% |
| Dec 31, 2024 | 16.00B | -57.80% |
| Dec 29, 2023 | 37.92B | -45.05% |
| Dec 30, 2022 | 69.01B | -32.99% |
| Dec 31, 2021 | 102.98B | 149.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vertex Pharmaceuticals | 132.80B |
| Regeneron Pharmaceuticals | 80.39B |
| argenx SE | 54.78B |
| BeOne Medicines AG | 42.94B |
| Revolution Medicines | 40.08B |
| Royalty Pharma | 36.72B |
| Alnylam Pharmaceuticals | 29.98B |
| Roivant Sciences | 26.36B |